Finzati - Logo
NRC logo

NRC Health

NRC • Medical - Healthcare Information Services
$21.53
▲ +0.28 (+1.32%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$473.85M
Growth
8.4%
Cash Flow
5/5
Trend
Stable
Evidence
Stable or improving margins · 8.4%Positive free cash flow · 0.7Consistent free cash flow · 5/5Expensive earnings multiple · 36.22High debt level · 5.65
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 6, 2026, 1:11 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$21.53
Change1.32%
Shares Out22.01M
Market Cap$473.85M
Enterprise Value$560.55M
52W Range11.01 - 23.68
Beta0.38
P/E80.90
P/S3.38
P/B72.36
P/FCF21.90
EV/Sales4.00

Investment DNA

How strong this company looks for long-term investors

51
out of 100
Business Quality
Margins, moat, returns
57/100
Financial Strength
Debt, cash, stability
29/100
Growth Potential
Revenue and expansion
27/100
Price Attractiveness
Cheap or expensive today
48/100
Why this score▼
Stable or improving margins · 8.4%Positive free cash flow · 0.7Consistent free cash flow · 5/5Expensive earnings multiple · 36.22High debt level · 5.65Weak liquidity · 0.55

Analyst view

Analyst sentiment and price target

NRC
Analyst sentiment
Based on 1 analyst votes · 2026-09-05
100/100
Bullish
Bullish
1
Hold
0
Bearish
0

Company Overview

IPO: 5/23/2013
Industry: Medical - Healthcare Information Services
P/B i: 72.36
Debt / Equity i: 5.65
Operating Margin: 16.44%
Net Margin: 8.44%
ROE i: -
ROIC: -

Financial Health

Score6 / 20
Debt / Equity: 5.65
Current Ratio: 0.55
Quick Ratio: 0.55
Status: Weak

Warnings

  • High debt level
  • Weak Liquidity
  • Weak quick ratio

Insider Transactions

Recent executive and insider activity

Wheeler Penny Ann
Transaction: 06/23/2026
BUY
Change
+7,697
Price
Not reported
Filing
06/25/2026
Type
BUY
NUNNELLY JOHN N
Transaction: 06/23/2026
BUY
Change
+7,697
Price
Not reported
Filing
06/25/2026
Type
BUY
Lockhart Stephen H
Transaction: 06/23/2026
BUY
Change
+7,697
Price
Not reported
Filing
06/25/2026
Type
BUY